229 related articles for article (PubMed ID: 8911654)
1. Neurohormonal perturbations in fibromyalgia.
Crofford LJ; Engleberg NC; Demitrack MA
Baillieres Clin Rheumatol; 1996 May; 10(2):365-78. PubMed ID: 8911654
[TBL] [Abstract][Full Text] [Related]
2. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.
Torpy DJ; Papanicolaou DA; Lotsikas AJ; Wilder RL; Chrousos GP; Pillemer SR
Arthritis Rheum; 2000 Apr; 43(4):872-80. PubMed ID: 10765933
[TBL] [Abstract][Full Text] [Related]
3. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia.
Crofford LJ; Pillemer SR; Kalogeras KT; Cash JM; Michelson D; Kling MA; Sternberg EM; Gold PW; Chrousos GP; Wilder RL
Arthritis Rheum; 1994 Nov; 37(11):1583-92. PubMed ID: 7980669
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine immunology of fibromyalgia.
Di Franco M; Iannuccelli C; Valesini G
Ann N Y Acad Sci; 2010 Apr; 1193():84-90. PubMed ID: 20398012
[TBL] [Abstract][Full Text] [Related]
5. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain.
Griep EN; Boersma JW; Lentjes EG; Prins AP; van der Korst JK; de Kloet ER
J Rheumatol; 1998 Jul; 25(7):1374-81. PubMed ID: 9676772
[TBL] [Abstract][Full Text] [Related]
6. Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome.
Crofford LJ; Demitrack MA
Rheum Dis Clin North Am; 1996 May; 22(2):267-84. PubMed ID: 8860799
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine abnormalities in fibromyalgia and related disorders.
Crofford LJ
Am J Med Sci; 1998 Jun; 315(6):359-66. PubMed ID: 9638892
[TBL] [Abstract][Full Text] [Related]
8. The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and chronic fatigue syndrome.
Crofford LJ
Z Rheumatol; 1998; 57 Suppl 2():67-71. PubMed ID: 10025087
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine and hormonal perturbations and relations to the serotonergic system in fibromyalgia patients.
Neeck G
Scand J Rheumatol Suppl; 2000; 113():8-12. PubMed ID: 11028824
[TBL] [Abstract][Full Text] [Related]
10. Blunted ACTH and cortisol responses to systemic injection of corticotropin-releasing hormone (CRH) in fibromyalgia: role of somatostatin and CRH-binding protein.
Riedel W; Schlapp U; Leck S; Netter P; Neeck G
Ann N Y Acad Sci; 2002 Jun; 966():483-90. PubMed ID: 12114308
[TBL] [Abstract][Full Text] [Related]
11. Hormonal pertubations in fibromyalgia syndrome.
Neeck G; Riedel W
Ann N Y Acad Sci; 1999 Jun; 876():325-38; discussion 339. PubMed ID: 10415628
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine mechanisms in fibromyalgia-chronic fatigue.
Buskila D; Press J
Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):747-58. PubMed ID: 11812019
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome.
Neeck G; Crofford LJ
Rheum Dis Clin North Am; 2000 Nov; 26(4):989-1002. PubMed ID: 11084955
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine abnormalities in fibromyalgia.
Adler GK; Manfredsdottir VF; Creskoff KW
Curr Pain Headache Rep; 2002 Aug; 6(4):289-98. PubMed ID: 12095464
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine therapy of fibromyalgia syndrome: an update.
Sarzi-Puttini P; Atzeni F; Cazzola M
Ann N Y Acad Sci; 2010 Apr; 1193():91-7. PubMed ID: 20398013
[TBL] [Abstract][Full Text] [Related]
16. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome.
Demitrack MA; Crofford LJ
Ann N Y Acad Sci; 1998 May; 840():684-97. PubMed ID: 9629295
[TBL] [Abstract][Full Text] [Related]
17. Attenuated adrenergic responses to exercise in women with fibromyalgia--a controlled study.
Giske L; Vøllestad NK; Mengshoel AM; Jensen J; Knardahl S; Røe C
Eur J Pain; 2008 Apr; 12(3):351-60. PubMed ID: 17827042
[TBL] [Abstract][Full Text] [Related]
18. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals.
Glass JM; Lyden AK; Petzke F; Stein P; Whalen G; Ambrose K; Chrousos G; Clauw DJ
J Psychosom Res; 2004 Oct; 57(4):391-8. PubMed ID: 15518675
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
[TBL] [Abstract][Full Text] [Related]
20. A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome.
Kirnap M; Colak R; Eser C; Ozsoy O; Tutus A; Kelestimur F
Clin Endocrinol (Oxf); 2001 Oct; 55(4):455-9. PubMed ID: 11678827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
